SOMAÍ Pharmaceuticals

SOMAÍ Pharmaceuticals, with its slogan "We Craft Care," has emerged as a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) in the biopharma, biotechnology, and pharmaceutical industries. Established in 2019 and headquartered in Portugal, the company has positioned itself with a global distribution footprint for its extensive EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio, advancing the vision of a world where natural cannabis medicine empowers a healthy lifestyle. The company's operations are backed by a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, complemented by global sales teams in the largest medical cannabis markets. This foundation has allowed SOMAÍ to become one of the few and the first European-based vertically integrated companies in the EU, capable of meeting the diverse needs of the rapidly evolving global cannabis markets. Notably, SOMAÍ Pharmaceuticals secured a significant milestone with its €14.70M Series B investment on 15 July 2024, showcasing investor confidence in the company's strategic direction and growth potential. As the company continues to make acquisitions and foster global brand partnerships, SOMAÍ is steadfast in its mission to establish a leading global brand with an innovative pipeline of cannabis-based therapeutics, contributing to the evolution of the pharmaceutical landscape.